Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Gynecologic 1

Conditions

Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Precancerous Conditions 1

Interventions

Colposcopy 5Biopsy 3Vaginal Smears 2Polymerase Chain Reaction 2Imiquimod 2human papillomavirus vaccine, TA 1human papillomavirus vaccine, L1 type 16, 18 1Zoledronic Acid 1Watchful Waiting 1Tretinoin 1Transurethral Resection of Prostate 1Spectrum Analysis 1Spectrometry, Fluorescence 1Sodium Chloride 1Pregnancy Tests 1Papanicolaou Test 1Microarray Analysis 1Immunohistochemistry 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Human Papillomavirus DNA Tests 1Histological Techniques 1Folic Acid 1Fluorophotometry 1Flow Cytometry 1Fenretinide 1Eflornithine 1Conization 1Acetic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Uterine Cervical Dysplasia × Zoledronic Acid × Other neoplasm × Clear all
NCT00278434 2017-11-24

Zoledronate in Treating Patients With Cervical Intraepithelial Neoplasia 2/3 or 3

University of California, San Francisco

Phase 1 Terminated
12 enrolled
GynecologicOther neoplasm

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡